Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

Marie Skłodowska-Curie Action · Running

TRILOGY Ultrafast Chirality for Life and Technology

Coordinator
Forschungsverbund Berlin eV, Germany
Runs
1 March 2026 to 28 February 2030
Status
Running
EU funding
€4.6m
Total cost
—
Partners
29 organisations in 10 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101226887

What the project is doing

In the project's own words, from its summary on CORDIS.

TRILOGY establishes the interface between the emerging field of Ultrafast Chirality and its Life and Technology applications by using attosecond electronic response to light, the fastest agent in mediating electric signals, highlighted by the 2023 Physics Nobel Prize. Chirality, a dissymmetry between a molecule and its mirror image, is a synonym of life: it enables metabolic reactions and stability of proteins. Abnormal chirality is an indicator for cancer cells, brain or kidney diseases, but its accurate detection requires a combination of high precision and speed, where attosecond response to light gives clear advantage to optical methods.

Standard chiro-optical methods are fundamentally limited in accuracy by a ratio of molecular size to the light wavelength. Resolving ultrafast electron dynamics we remove this limitation and break into a new regime with chiral signals outperforming standard methods by severalorders of magnitude. We will take advantage of this paradigm shift in chiral measurements and develop new efficient ultrafast spectroscopies for discriminating medium sized chiral biomolecules and elucidating charge and spin transport in chiral media at the most fundamental level: the level of electrons.

We overlap the training and innovation landscapes in a unique way inspired by a common drive to bring cutting-edge scientific developments to applications, enabled by strong involvement of industry. We will (i) integrate our methods with existing analytics for quick market adaptation, working with the market leader for mass spectrometry(ThermoFisher), (ii) further them to unprecedentedly high throughput enabled by laser technology (Amplitude) and state-of-the-art imaging (PIimaging).

We will make a difference, motivate and inspire young minds, training a new generation of researchers at the interface of fundamental science, technology and high-tech industry to bring cutting edge research through industrial applications to the benefit of the society.

Topics

Who is involved

OrganisationCityCountryRole
Forschungsverbund Berlin eVBerlinGermanyCoordinator
Universitaet InnsbruckInnsbruckAustriaAssociatedpartner
Universite De LiegeLiegeBelgiumParticipant
Ecole Polytechnique Federale De LausanneLausanneSwitzerlandAssociatedpartner
Pi Imaging Technology SALausanneSwitzerlandAssociatedpartner
Universite De GeneveGeneveSwitzerlandAssociatedpartner
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eVMunchenGermanyAssociatedpartner
Springer Nature AG & Co. KGaABerlinGermanyAssociatedpartner
Technische Universitat BerlinBerlinGermanyAssociatedpartner
Thermo Fisher Scientific (bremen) GmbHBremenGermanyParticipant
Universitaet KasselKasselGermanyAssociatedpartner
University of HamburgHamburgGermanyParticipant
AmplitudePessacFranceAssociatedpartner
Centre National De La Recherche Scientifique CNRSParisFranceParticipant
Institut D'optique Theorique Et Appliquee Iota - SupoptiquePalaiseauFranceParticipant
Synchrotron Soleil Societe CivileSaint AubinFranceAssociatedpartner
Universite De BordeauxBordeauxFranceAssociatedpartner
Universite Paris-SaclayGif-Sur-YvetteFranceAssociatedpartner
Technion - Israel Institute of TechnologyHaifaIsraelAssociatedpartner
Weizmann Institute of ScienceRehovotIsraelParticipant
Consiglio Nazionale Delle RicercheRomaItalyParticipant
Politecnico Di MilanoMilanoItalyAssociatedpartner
Asml Netherlands B.v.VeldhovenNetherlandsAssociatedpartner
MassSpecpecD BVEnschedeNetherlandsAssociatedpartner
Universiteit TwenteEnschedeNetherlandsAssociatedpartner
Lunds UniversitetLundSwedenParticipant
Heriot-Watt UniversityEdinburghUnited KingdomParticipant
Imperial College of Science Technology and MedicineLondonUnited KingdomParticipant
The University of NottinghamNottinghamUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS